Interview with Dr. Sungwon Lim, CEO of ImpriMed

August 10, 2021
Dr. Sungwon Lim Interview Video Thumbnail

This podcast interview was produced and published by Scott Amyx.com.

---

Today I am joined by Dr. Sungwon Lim, CEO and Co-Founder of ImpriMed, Inc., which uses artificial intelligence on live cancer cell analytics to predict how a patient will respond to cancer therapy drugs before taking them. Sungwon received his PhD degree in Bioengineering from Stanford University and a master’s degree in Translational Medicine from the UC Berkeley–UCSF Joint Bioengineering Program. He is a bioengineer and entrepreneur with 20 years of collective experiences in academia and biotech companies, especially focusing on the development of novel cancer therapies. He is a strong advocate of functional precision medicine – personalizing a cancer treatment regimen based on each patient’s cancer cells’ functional responses to anti-cancer drugs, beyond cancer genetics.


Scott Amyx

Innovation Keynote Speaker | Trend Spotter | Experiential, Interactive, Engaging
www.scottamyx.com

Energize, inspire & engage your audience. Book Scott Amyx today for valuable insights into the future of work, productivity & society.


About Scott Amyx

Scott Amyx is the Managing Partner at Astor Perkins, Forbes New York Business Council Member, Singularity University/ Smart City Accelerator mentor and startup board member and SXSW Pitch (formerly SXSW Accelerator) judge. Scott is a Tribeca Disruptor Foundation Fellow, a disruptive innovation awards program of Tribeca Film Festival. Scott is a national Sloan Fellow/ Woodrow Wilson Fellow. He has spoken at TEDx on exponential technologies, Fourth Industrial Revolution & success. Scott is a global thought leader, futurist, voted top 10 international keynote speaker, & author on smart cities, the Fourth Industrial Revolution and winner of the Cloud & DevOps World Award for Most Innovative and was voted Top Global Exponential Technologies Expert by Inc. Magazine, HP Enterprise, and Postscapes & Top 10 Global Keynote Speakers by Speaking.com. Scott has been nominated to the World Economic Forum as a committee member for the Future of the Internet. The Republic of Korea nominated Scott to present at the ITU Telecom World, United Nations. Sovereignties, governments, multinationals, and international consulting & research firms look to Scott for unrivaled insights and pulse on the changing landscape.

Scott has been featured on New York Times, TIME, Forbes, The Washington Post, WIRED, TechCrunch, Inc., Pew Research, Chicago Tribune, InformationWeek, Forrester, & television & radio programs. He has spoken or scheduled to speak at TED, European Commission, World Economic Forum, ITU Telecom World/United Nations, International CES, Internet of Things World, IBM Insight, Amplify, Watson IoT, InterConnect, Cloud Expo Europe, & more. Scott is the co-author of Internet of Things and Data Analytics Handbook, an academic publication by John Wiley and Sons and The Advances in Information Security, Privacy, & Ethics Book Series: Managing Security Issues and the Hidden Dangers of Wearable Technologies, an academic publication by IGI Global.

Video/Podcast Interviews

AI, Cancer & the Future of Pet Care with Dr Ilona Holcomb

The Pets Mag Podcast
Learn More →

Sit, Stay, and Heal: Bringing Precision Medicine to Dogs, then Humans

The Bio Report
Learn More →

From Dogs to Humans: The Power of Precision Medicine with Dr. Lim

Target Cancer Podcast
Learn More →

Personalized Medicine in Veterinary Oncology

Veterinary Innovation Podcast
Learn More →

Tech Founder Interview with Sungwon Lim, CEO & Founder of ImpriMed

Tech Founder Show by Insivia
Learn More →

Which Drugs Can Kill Your Dog's Cancer Cells? - ImpriMed's Sungwon Lim | Canine Cancer Rebel

Canine Cancer Alliance
Learn More →

Interview with Sungwon Lim: Founder & CEO of ImpriMed

Entrepreneurship, Interviews, Level Up!
Learn More →